Migraine Headache Medication, Drugs & Medicine

Latest Health Related News:
Drug For Treatment Of Inflammatory Bowel Disease - New Formula Allows For Greater Absorption, Fewer Doses
Physician-scientists from NewYork-Presbyterian/Weill Cornell, involved in clinical trials for a new drug for those who suffer from inflammatory bowel disease (IBD), say it is the best option among available drugs. Gaizo is a reformulation of the active ingredient 5-ASA in currently available drugs. However, the researchers found that 99 percent of the active ingredient in the new pill is released in the colon compared to only 70 percent in other common IBD drugs. Dr.
Protein Targets Identified For Malaria Vaccine
According to a new study published in the open-access journal PLoS Pathogens, Dutch researchers have identified and characterized several parasite proteins that potentially may be used to design a human malaria vaccine. Africa loses 2000 children every day from malaria, a disease that humans contract from mosquitoes.
Alte Biosciences Files Patent For New Inflammatory Bowel Disease Drugs - Unique Compositions Of Matter To Treat Gastrointestinal Disorders
Alte Bioscience, Inc., a development stage pharmaceutical company, is pleased to announce the filing of a provisional patent for a new class of drugs that may benefit patients with inflammatory bowel disease. This is the latest in a series of pharmaceutical inventions held by Alte Biosciences, adding to its portfolio of patents of drugs for the treatment of late onset depression and innovative systems for drug delivery, packaging, and manufacturing.